- call +1-201-465-4211
- email sales@mrinsights.biz
Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
Scope of the Report:
This report focuses on the Dermatophytic Onychomycosis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
The global dermatophytic onychomycosis market is intensely competitive owing to the presence of numerous small and large vendors that operate at a local or global scale. To survive and succeed in this market, the vendors enter into strategic alliances with smaller players to manufacture and market new drugs.
The Americas dominated this market and is envisaged to retain its dominating market position by the end of 2020 owing to the presence of a well-developed healthcare system
The worldwide market for Dermatophytic Onychomycosis is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Anacor Pharmaceuticals
Galderma
Janssen Biotech
Novartis
Valeant Pharmaceuticals
Abeona Therapeutics
Allergan
Elorac
GlaxoSmithKline
Hexima
Hisamitsu Pharmaceutical
Mayne Pharma
MediQuest Therapeutics
Meiji Seika Pharma
Merz Pharma
Moberg Pharma
NanoBio
NovaBiotics
Nuvo Research
Pfizer
Polichem
Promius Pharma
Sanofi
Seren Pharmaceuticals
Taro Pharmaceutical
Topica Pharmaceuticals
Viamet Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Topical
Market Segment by Applications, can be divided into
Hospitals
Clinics and laboratories
Others
There are 15 Chapters to deeply display the global Dermatophytic Onychomycosis market.
Chapter 1, to describe Dermatophytic Onychomycosis Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Dermatophytic Onychomycosis, with sales, revenue, and price of Dermatophytic Onychomycosis, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatophytic Onychomycosis, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Dermatophytic Onychomycosis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Dermatophytic Onychomycosis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Dermatophytic Onychomycosis Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Topical
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics and laboratories
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Anacor Pharmaceuticals
2.1.1 Business Overview
2.1.2 Dermatophytic Onychomycosis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Galderma
2.2.1 Business Overview
2.2.2 Dermatophytic Onychomycosis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Galderma Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Janssen Biotech
2.3.1 Business Overview
2.3.2 Dermatophytic Onychomycosis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Janssen Biotech Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Dermatophytic Onychomycosis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valeant Pharmaceuticals
2.5.1 Business Overview
2.5.2 Dermatophytic Onychomycosis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Valeant Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abeona Therapeutics
2.6.1 Business Overview
2.6.2 Dermatophytic Onychomycosis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abeona Therapeutics Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Allergan
2.7.1 Business Overview
2.7.2 Dermatophytic Onychomycosis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Allergan Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Elorac
2.8.1 Business Overview
2.8.2 Dermatophytic Onychomycosis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Elorac Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithKline
2.9.1 Business Overview
2.9.2 Dermatophytic Onychomycosis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithKline Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Hexima
2.10.1 Business Overview
2.10.2 Dermatophytic Onychomycosis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hexima Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Hisamitsu Pharmaceutical
2.11.1 Business Overview
2.11.2 Dermatophytic Onychomycosis Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hisamitsu Pharmaceutical Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Mayne Pharma
2.12.1 Business Overview
2.12.2 Dermatophytic Onychomycosis Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Mayne Pharma Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MediQuest Therapeutics
2.13.1 Business Overview
2.13.2 Dermatophytic Onychomycosis Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 MediQuest Therapeutics Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Meiji Seika Pharma
2.14.1 Business Overview
2.14.2 Dermatophytic Onychomycosis Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Meiji Seika Pharma Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Merz Pharma
2.15.1 Business Overview
2.15.2 Dermatophytic Onychomycosis Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Merz Pharma Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Moberg Pharma
2.16.1 Business Overview
2.16.2 Dermatophytic Onychomycosis Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Moberg Pharma Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 NanoBio
2.17.1 Business Overview
2.17.2 Dermatophytic Onychomycosis Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 NanoBio Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 NovaBiotics
2.18.1 Business Overview
2.18.2 Dermatophytic Onychomycosis Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 NovaBiotics Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Nuvo Research
2.19.1 Business Overview
2.19.2 Dermatophytic Onychomycosis Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Nuvo Research Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Pfizer
2.20.1 Business Overview
2.20.2 Dermatophytic Onychomycosis Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Pfizer Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Polichem
2.21.1 Business Overview
2.2.2 Dermatophytic Onychomycosis Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Polichem Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Promius Pharma
2.22.1 Business Overview
2.22.2 Dermatophytic Onychomycosis Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Promius Pharma Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Sanofi
2.23.1 Business Overview
2.23.2 Dermatophytic Onychomycosis Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Sanofi Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.24 Seren Pharmaceuticals
2.24.1 Business Overview
2.24.2 Dermatophytic Onychomycosis Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Seren Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.25 Taro Pharmaceutical
2.25.1 Business Overview
2.25.2 Dermatophytic Onychomycosis Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Taro Pharmaceutical Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.26 Topica Pharmaceuticals
2.26.1 Business Overview
2.26.2 Dermatophytic Onychomycosis Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Topica Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.27 Viamet Pharmaceuticals
2.27.1 Business Overview
2.27.2 Dermatophytic Onychomycosis Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Viamet Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dermatophytic Onychomycosis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Dermatophytic Onychomycosis Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dermatophytic Onychomycosis Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatophytic Onychomycosis Manufacturer Market Share in 2017
3.3.2 Top 6 Dermatophytic Onychomycosis Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Dermatophytic Onychomycosis Market Analysis by Regions
4.1 Global Dermatophytic Onychomycosis Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatophytic Onychomycosis Sales and Market Share by Regions (2013-2018)
4.1.2 Global Dermatophytic Onychomycosis Revenue and Market Share by Regions (2013-2018)
4.2 North America Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
4.3 Europe Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
4.5 South America Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
5 North America Dermatophytic Onychomycosis by Countries
5.1 North America Dermatophytic Onychomycosis Sales, Revenue and Market Share by Countries
5.1.1 North America Dermatophytic Onychomycosis Sales and Market Share by Countries (2013-2018)
5.1.2 North America Dermatophytic Onychomycosis Revenue and Market Share by Countries (2013-2018)
5.2 United States Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
5.3 Canada Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
5.4 Mexico Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
6 Europe Dermatophytic Onychomycosis by Countries
6.1 Europe Dermatophytic Onychomycosis Sales, Revenue and Market Share by Countries
6.1.1 Europe Dermatophytic Onychomycosis Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Dermatophytic Onychomycosis Revenue and Market Share by Countries (2013-2018)
6.2 Germany Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
6.3 UK Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
6.4 France Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
6.5 Russia Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
6.6 Italy Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
7 Asia-Pacific Dermatophytic Onychomycosis by Countries
7.1 Asia-Pacific Dermatophytic Onychomycosis Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Dermatophytic Onychomycosis Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Dermatophytic Onychomycosis Revenue and Market Share by Countries (2013-2018)
7.2 China Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
7.3 Japan Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
7.4 Korea Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
7.5 India Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
8 South America Dermatophytic Onychomycosis by Countries
8.1 South America Dermatophytic Onychomycosis Sales, Revenue and Market Share by Countries
8.1.1 South America Dermatophytic Onychomycosis Sales and Market Share by Countries (2013-2018)
8.1.2 South America Dermatophytic Onychomycosis Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
8.3 Argentina Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
8.4 Colombia Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
9 Middle East and Africa Dermatophytic Onychomycosis by Countries
9.1 Middle East and Africa Dermatophytic Onychomycosis Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dermatophytic Onychomycosis Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Dermatophytic Onychomycosis Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
9.3 UAE Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
9.4 Egypt Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
9.5 Nigeria Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
9.6 South Africa Dermatophytic Onychomycosis Sales and Growth Rate (2013-2018)
10 Global Dermatophytic Onychomycosis Market Segment by Type
10.1 Global Dermatophytic Onychomycosis Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Dermatophytic Onychomycosis Sales and Market Share by Type (2013-2018)
10.1.2 Global Dermatophytic Onychomycosis Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 Topical Sales Growth and Price
10.3.1 Global Topical Sales Growth (2013-2018)
10.3.2 Global Topical Price (2013-2018)
11 Global Dermatophytic Onychomycosis Market Segment by Application
11.1 Global Dermatophytic Onychomycosis Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics and laboratories Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Dermatophytic Onychomycosis Market Forecast (2018-2023)
12.1 Global Dermatophytic Onychomycosis Sales, Revenue and Growth Rate (2018-2023)
12.2 Dermatophytic Onychomycosis Market Forecast by Regions (2018-2023)
12.2.1 North America Dermatophytic Onychomycosis Market Forecast (2018-2023)
12.2.2 Europe Dermatophytic Onychomycosis Market Forecast (2018-2023)
12.2.3 Asia-Pacific Dermatophytic Onychomycosis Market Forecast (2018-2023)
12.2.4 South America Dermatophytic Onychomycosis Market Forecast (2018-2023)
12.2.5 Middle East and Africa Dermatophytic Onychomycosis Market Forecast (2018-2023)
12.3 Dermatophytic Onychomycosis Market Forecast by Type (2018-2023)
12.3.1 Global Dermatophytic Onychomycosis Sales Forecast by Type (2018-2023)
12.3.2 Global Dermatophytic Onychomycosis Market Share Forecast by Type (2018-2023)
12.4 Dermatophytic Onychomycosis Market Forecast by Application (2018-2023)
12.4.1 Global Dermatophytic Onychomycosis Sales Forecast by Application (2018-2023)
12.4.2 Global Dermatophytic Onychomycosis Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Dermatophytic Onychomycosis Picture
Table Product Specifications of Dermatophytic Onychomycosis
Figure Global Sales Market Share of Dermatophytic Onychomycosis by Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
